FDA Inspection 964577 — Morton Grove Pharmaceuticals, Inc.

Morton Grove Pharmaceuticals, Inc. — FEI 1420913

The FDA completed an inspection of Morton Grove Pharmaceuticals, Inc. on Feb 5, 2016 in Morton Grove, IL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Feb 5, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Morton Grove, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.